Women's health: The struggle to restore hormonal balance

American Journal of Medicine

Volumn 118, Issue 11, 2005, Pages 1181-1182

  Stopeck, Alison T ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANGELICA SINENSIS EXTRACT; ANTIDEPRESSANT AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CIMICIFUGA RACEMOSA EXTRACT; CLONIDINE; CONJUGATED ESTROGEN; ESTROGEN; GABAPENTIN; GESTAGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LUBRICATING AGENT; PARATHYROID HORMONE; PAROXETINE; PHYTOESTROGEN; PRIMROSE OIL; RED CLOVER EXTRACT; VENLAFAXINE; VITAMIN D;

ANGELICA SINENSIS; BREAST CANCER; CANCER RISK; CARDIOVASCULAR DISEASE; CIMICIFUGA RACEMOSA; COGNITION; DRUG SAFETY; DYSPAREUNIA; EDITORIAL; ESTROGEN THERAPY; EVENING PRIMROSE; FEMALE; HEALTH CARE ORGANIZATION; HEALTH INSURANCE; HEALTH STATUS; HEART DISEASE; HORMONAL REGULATION; HORMONE SUBSTITUTION; HUMAN; MENOPAUSAL SYNDROME; MENOPAUSE; OSTEOPOROSIS; PHYSICAL PERFORMANCE; POSTMENOPAUSE; PRIORITY JOURNAL; QUALITY OF LIFE; RED CLOVER; SOYBEAN; TREATMENT OUTCOME;

ADULT; AGED; BREAST NEOPLASMS; CLINICAL TRIALS; COMPLEMENTARY THERAPIES; CULTURE; ESTROGENS; FEAR; FEMALE; HEART DISEASES; HORMONE REPLACEMENT THERAPY; HUMANS; LONGEVITY; MENOPAUSE; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; PERIMENOPAUSE; PHYTOESTROGENS; PHYTOTHERAPY; PROGESTINS; RISK ASSESSMENT; WOMEN'S HEALTH;

EID: 27644527798     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2005.08.037     Document Type: Editorial

References (10)

1. D. Grady, D. Herrington, V. Bittner HERS Research Group Cardiovascular disease outcomes during 6.8 years of hormone therapy heart and estrogen/progestin replacement study follow-up (HERS II) JAMA 288 2002 49 57
2. Writing Group for the Women's Health Initiative Investigators Risks and benefits of estrogen plus progestin in healthy postmenopausal women Principal results from the women's health initiative randomized controlled trial JAMA 288 2002 321 333
3. S.R. Rapp, M.A. Espeland, S.A. Shumaker Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial JAMA 289 2003 2663 2672
4. S.L. Greenspan, N.M. Resnick, R.A. Parker Combination therapy with hormone replacement and alendronate for prevention of bone loss in elderly women JAMA 289 2003 2525 2533
5. R.M. Neer, C.D. Arnaud, J.R. Zanchetta Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis N Engl J Med 344 2001 1434 1441
6. A.L. Hersh, M.L. Stefanick, R.S. Stafford National use of postmenopausal hormone therapy annual trends and response to recent evidence JAMA 291 2004 47 53
7. Poll conducted by International Communications Research of Media, Pa., for the Society for Women's Health Research, June 22-29, 2005.
8. The Women's Health Initiative Steering Committee Effects of conjugated equine estrogen in postmenopausal women with hysterectomy The Women's Health Initiative randomized controlled trial JAMA 291 2004 1701 1712
9. North American Menopause Society Treatment of menopause-associated vasomotor symptoms position statement of The North American Menopause Society Menopause 11 2004 11 33
10. M. Hickey, S.R. Davis, D.W. Sturdee Treatment of menopausal symptoms what shall we do now? Lancet 366 2005 409 421